Lyon 2020 HFA-ICOS baseline CV risk before VEGF inhibitors or VEGF TKIs
Lyon 2020 HFA-ICOS baseline CV risk before VEGF inhibitors or VEGF TKIs. Very high if heart failure/cardiomyopathy or arterial vascular disease. High if venous thrombosis, LVEF <50%, QTc >=480 ms, age >=75, hypertension, prior anthracycline, or >=5 medium points. Medium if 2-4 medium points. Guide <2% / 2-9% / 10-19% / >=20%. Not a device or treatment order.
Asked 1.4x its listed price for its own exampleour last check, 2026-09-28
1 of 1checks answered this week
374 msmedian answer time
$0.005listed price per call
$0.007price it asked us
Paid test badge: not yet. The checks above are free: we call the tool without paying and read the payment request it sends back. The Verified badge needs paid calls whose answers match the promised output, and nobody can buy a badge.
Endpoint
POST https://api.magentlab.com/api/calc/hfa_icos_vegf
| Category | Everything else |
|---|---|
| Provider host | api.magentlab.com |
| Networks | eip155:8453 |
| Payment schemes | exact |
| Self-reported calls, 30 days | 0 from 0 payers (the provider's figure, not ours) |
Our checks, last 30 days
| Day | Result | HTTP | Asked | Time |
|---|---|---|---|---|
| 2026-09-28 | valid payment request | 402 | $0.007 | 374 ms |
Example input (from the provider)
{
"body": {
"items": [
{
"age_years": 50,
"arrhythmia": false,
"arterial_vascular_disease": false,
"ckd": false,
"current_or_significant_smoker": false,
"diabetes": false,
"elevated_bnp": false,
"elevated_troponin": false,
"heart_failure_or_cardiomyopathy": false,
"hyperlipidemia": false,
"hypertension": false,
"lvef_percent": 60,
"obesity": false,
"prior_anthracycline": false,
"prior_left_chest_or_mediastinal_rt": false,
"proteinuria": false,
"qtc_ms": 400,
"sex": "female",
"venous_thrombosis": false
},
{
"age_years": 50,
"arrhythmia": false,
"arterial_vascular_disease": false,
"ckd": false,
"current_or_significant_smoker": false,
"diabetes": false,
"elevated_bnp": false,
"elevated_troponin": false,
"heart_failure_or_cardiomyopathy": false,
"hyperlipidemia": false,
"hypertension": false,
"lvef_percent": 60,
"obesity": false,
"prior_anthracycline": false,
"prior_left_chest_or_mediastinal_rt": false,
"proteinuria": false,
"qtc_ms": 400,
"sex": "female",
"venous_thrombosis": false
}
]
},
"method": "POST",
"type": "http"
}
Promised output schema (from the provider)
{
"$schema": "https://json-schema.org/draft/2020-12/schema",
"properties": {
"input": {
"additionalProperties": false,
"properties": {
"body": {
"additionalProperties": false,
"properties": {
"items": {
"items": {
"properties": {
"age_years": {
"description": "Integer age in years (18-100) as assigned by the caller. Lyon 2020 VEGF-inhibitor table: >=75 High; 65-74 Medium 1; <65 no age points. Bands are exclusive. magent does not read an identity document.",
"type": "integer"
},
"arrhythmia": {
"description": "Arrhythmia (atrial fibrillation, atrial flutter, ventricular tachycardia, or ventricular fibrillation) as assigned by the caller (Lyon 2020 VEGF-inhibitor table, Medium 2). true or false.",
"type": "boolean"
},
"arterial_vascular_disease": {
"description": "Arterial vascular disease: IHD, PCI, CABG, stable angina, TIA, stroke, or PVD as one caller bool (Lyon 2020 VEGF-inhibitor table, very high). true or false. magent does not diagnose vascular disease.",
"type": "boolean"
},
"ckd": {
"description": "Chronic kidney disease (eGFR <60 mL/min/1.73 m2) as assigned by the caller (Lyon 2020 VEGF-inhibitor table, Medium 1). true or false. magent does not compute eGFR.",
"type": "boolean"
},
"current_or_significant_smoker": {
"description": "Current smoker or significant smoking history as assigned by the caller (Lyon 2020 VEGF-inhibitor table, Medium 1). true or false.",
"type": "boolean"
},
"diabetes": {
"description": "Diabetes mellitus (glycated haemoglobin >7.0% or >53 mmol/mol, or on treatment) as assigned by the caller (Lyon 2020 VEGF-inhibitor table, Medium 1). true or false.",
"type": "boolean"
},
"elevated_bnp": {
"description": "Elevated baseline BNP or NT-proBNP above the local laboratory upper limit of normal as assigned by the caller (Lyon 2020 VEGF-inhibitor table, Medium 1). true or false. magent does not assay BNP.",
"type": "boolean"
},
"elevated_troponin": {
"description": "Elevated baseline troponin above the local laboratory upper limit of normal as assigned by the caller (Lyon 2020 VEGF-inhibitor table, Medium 1). true or false. magent does not assay troponin.",
"type": "boolean"
},
"heart_failure_or_cardiomyopathy": {
"description": "Heart failure or cardiomyopathy (Lyon 2020 VEGF-inhibitor table, very high). Caller-assigned. true or false.",
"type": "boolean"
},
"hyperlipidemia": {
"description": "Hyperlipidemia (non-HDL cholesterol >3.8 mmol/L or >145 mg/dL) as assigned by the caller (Lyon 2020 VEGF-inhibitor table, Medium 1). true or false. magent does not convert lipid units.",
"type": "boolean"
},
"hypertension": {
"description": "Hypertension (SBP >140 mmHg or DBP >90 mmHg, or on treatment) as assigned by the caller (Lyon 2020 VEGF-inhibitor table, High). true or false. magent does not read a blood-pressure cuff.",
"type": "boolean"
},
"lvef_percent": {
"description": "Baseline left-ventricular ejection fraction, integer percent 10-80, as assigned by the caller. <50 High; 50-54 Medium 2; >=55 no LVEF points. magent does not read an echocardiogram.",
"type": "integer"
},
"obesity": {
"description": "Obesity (BMI >30 kg/m2) as assigned by the caller (Lyon 2020 VEGF-inhibitor table, Medium 1). true or false. magent does not compute BMI.",
"type": "boolean"
},
"prior_anthracycline": {
"description": "Prior anthracycline exposure as assigned by the caller (Lyon 2020 VEGF-inhibitor table, High). true or false.",
"type": "boolean"
},
"prior_left_chest_or_mediastinal_rt": {
"description": "Prior radiotherapy to the left chest or mediastinum as assigned by the caller (Lyon 2020 VEGF-inhibitor table, Medium 1). true or false.",
"type": "boolean"
},
"proteinuria": {
"description": "Proteinuria as assigned by the caller (Lyon 2020 VEGF-inhibitor table, Medium 1). true or false.",
"type": "boolean"
},
"qtc_ms": {
"description": "Baseline QTc in milliseconds, integer 300-700, as assigned by the caller. >=480 High; men 450-479 Medium 2; women 460-479 Medium 2. magent does not measure QTc.",
"type": "integer"
},
"sex": {
"description": "male or female as assigned by the caller. Used only for the sex-specific borderline QTc Medium 2 band (men 450-479 ms; women 460-479 ms).",
"type": "string"
},
"venous_thrombosis": {
"description": "Venous thrombosis (DVT or PE) as assigned by the caller (Lyon 2020 VEGF-inhibitor table, High). true or false.",
"type": "boolean"
}
},
"required": [
"age_years",
"sex",